Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1629-2024Class II

TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocation...

Howmedica Osteonics Corp / initiated 2024-02-27 / Open, Classified

Howmedica Osteonics Corp. began a recall of TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 742-11-50D on . FDA classified it as Class II and gives the reason as "The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1629-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Howmedica Osteonics Corp
Product
TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 742-11-50D
Product code
LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented
Reason for recall
The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell
FDA root cause
Under Investigation by firm
Action
Stryker issued Urgent Medical Device Recall (UMDR) PFA 3529813 by Sedgwick on Feb. 27, 2024, via UPS 2-day air. An OUS customer notification will also be issued at the country level. Letter states reason for recall and action to take: Technical and medical assessments are currently underway to determine any potential hazards and harms associated with the use of an impacted Trident II Acetabular Shell. An updated communication will be forwarded upon completion of the internal investigation of this issue. 1. Please inform users of this Urgent Medical Device Recall and forward this notice to all individuals who need to be made aware or organizations who have consigned product. 2. Immediately check all stock areas and/or operating room storage to determine if any devices from the affected product list are at your facility. 3. Quarantine and discontinue use of the recalled devices identified in the affected product list. 4. Complete and sign the enclosed Urgent Medical Device Recall Business Reply Form and email to " Medical Facility: Please sign the Business Reply Form and email to: [email protected] / Fax: (833) 237-1022 " Stryker Branch/Agency: please sign the AdobeSign form arriving to you via email. 5. Please contact your Local Sales Office or your Stryker Sales Representative directly for product replacement and inventory questions. 6. Please return the devices to Stryker using the following address: Stryker Orthopaedics/PFA Product Returns Attn: Distribution Inventory Team 325 Corporate Drive Dock M-East Mahwah, NJ 07430 Ref. PFA 3529813 If you have any questions or concerns after reviewing this letter, please contact Customer Service at (888)-756-7846. For questions pertaining to the recall, email [email protected]
Quantity in commerce
0
Distribution
Nationwide Foreign: Netherlands, Canada, Singapore, Spain, Sweden, UK
Product codes and lots
UDI-DI:(01)07613327381009(17)290313(10) Lot Number: 14593551 15432653 15432651

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1629-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1621-2024Class IIOngoingVoluntary: Firm initiated
Z-1622-2024Class IIOngoingVoluntary: Firm initiated
Z-1623-2024Class IIOngoingVoluntary: Firm initiated
Z-1624-2024Class IIOngoingVoluntary: Firm initiated
Z-1625-2024Class IIOngoingVoluntary: Firm initiated
Z-1626-2024Class IIOngoingVoluntary: Firm initiated
Z-1627-2024Class IIOngoingVoluntary: Firm initiated
Z-1628-2024Class IIOngoingVoluntary: Firm initiated
Z-1629-2024Class IIOngoingVoluntary: Firm initiated
Z-1630-2024Class IIOngoingVoluntary: Firm initiated
Z-1631-2024Class IIOngoingVoluntary: Firm initiated
Z-1632-2024Class IIOngoingVoluntary: Firm initiated